Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses

1. Palmer TM, Sterne JAC, Harbord RM, Lawlor DA, Sheehan NA, Meng S, et al. Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses. Am J Epidemiol. 2011;173:1392–1403. doi: 10.1093/aje/kwr026 21555716

2. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc. 1996;91:444–455.

3. Glymour MM, Tchetgen Tchetgen EJ, Robins JM. Credible Mendelian randomization studies: approaches for evaluating the instrumental variable assumptions. Am J Epidemiol. 2012;175:332–339. doi: 10.1093/aje/kwr323 22247045

4. VanderWeele TJ, Tchetgen Tchetgen EJ, Cornelis M, Kraft P. Methodological challenges in Mendelian randomization. Epidemiology. 2014;25:427–435. doi: 10.1097/EDE.0000000000000081 24681576

5. Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S, et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet. 2014;46:1173–1186. doi: 10.1038/ng.3097 25282103

6. Tang R, Zheng W, Li H, Gao Y, Shu X, Xiang Y. Prospective cohort study of body height and cancer incidence among adult men and women in Shanghai. Tumor. 2012;32:992–1000.

7. Albanes D, Jones DY, Schatzkin A, Micozzi MS, Taylor PR. Adult stature and risk of cancer. Cancer Res. 1988;48:1658–1662. 3345534

8. Drinkard C, Sellers T, Potter J, Zheng W, Bostick R, Nelson C, et al. Association of body-mass index and body-fat distribution with risk of lung-cancer in older women. Am J Epidemiol. 1995;142:600–607. 7653468

9. Hebert PR, Ajani U, Cook NR, Lee IM, Chan KS, Hennekens CH. Adult height and incidence of cancer in male physicians (United States). Cancer Causes Control. 1997;8:591–597. 9242474

10. Gunnell D, May M, Ben-Shlomo Y, Yarnell J, Smith GD. Height, leg length, and cancer: the Caerphilly Study. Nutr Cancer. 2003;47:34–39. doi: 10.1207/s15327914nc4701_4 14769535

11. Sung J, Song Y-M, Lawlor DA, Smith GD, Ebrahim S. Height and site-specific cancer risk: a cohort study of a Korean adult population. Am J Epidemiol. 2009;170:53–64. doi: 10.1093/aje/kwp088 19403842

12. Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V. Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol. 2011;12:785–794. doi: 10.1016/S1470-2045(11)70154-1 21782509

13. Kabat GC, Heo M, Kamensky V, Miller AB, Rohan TE. Adult height in relation to risk of cancer in a cohort of Canadian women. Int J Cancer. 2013;132:1125–1132. doi: 10.1002/ijc.27704 22753236

14. Kabat GC, Anderson ML, Heo M, Hosgood HD 3rd, Kamensky V, Bea JW, et al. Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2013;22:1353–1363. doi: 10.1158/1055-9965.EPI-13-0305 23887996

15. Walter RB, Brasky TM, Buckley SA, Potter JD, White E. Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst. 2013;105:860–868. doi: 10.1093/jnci/djt102 23708052

16. Kabat GC, Kim MY, Hollenbeck AR, Rohan TE. Attained height, sex, and risk of cancer at different anatomic sites in the NIH-AARP Diet and Health Study. Cancer Causes Control. 2014;25:1697–1706. doi: 10.1007/s10552-014-0476-1 25307804

17. Suadicani P, Hein HO, Gyntelberg F. Height, weight, and risk of colorectal cancer. An 18-year follow-up in a cohort of 5249 men. Scand J Gastroenterol. 1993;28:285–288. 8446855

18. Shimizu N, Nagata C, Shimizu H, Kametani M, Takeyama N, Ohnuma T, et al. Height, weight, and alcohol consumption in relation to the risk of colorectal cancer in Japan: a prospective study. Br J Cancer. 2003;88:1038–1043. doi: 10.1038/sj.bjc.6600845 12671701

19. MacInnis RJ, English DR, Hopper JL, Haydon AM, Gertig DM, Giles GG. Body size and composition and colon cancer risk in men. Cancer Epidemiol Biomarkers Prev. 2004;13:553–559. 15066919

20. Wei EK, Giovannucci E, Wu K, Rosner B, Fuchs CS, Willett WC, et al. Comparison of risk factors for colon and rectal cancer. Int J Cancer. 2004;108:433–442. doi: 10.1002/ijc.11540 14648711

21. Engeland A, Tretli S, Austad G, Bjorge T. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes Control. 2005;16:987–996. doi: 10.1007/s10552-005-3638-3 16132807

22. Otani T, Iwasaki M, Inoue M. Body mass index, body height, and subsequent risk of colorectal cancer in middle-aged and elderly Japanese men and women: Japan public health center-based prospective study. Cancer Causes Control. 2005;16:839–850. doi: 10.1007/s10552-005-4573-z 16132794

23. Bowers K, Albanes D, Limburg P, Pietinen P, Taylor PR, Virtamo J, et al. A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol. 2006;164:652–664. doi: 10.1093/aje/kwj253 16877536

24. MacInnis RJ, English DR, Haydon AM, Hopper JL, Gertig DM, Giles GG. Body size and composition and risk of rectal cancer (Australia). Cancer Causes Control. 2006;17:1291–1297. doi: 10.1007/s10552-006-0074-y 17111261

25. MacInnis RJ, English DR, Hopper JL, Gertig DM, Haydon AM, Giles GG. Body size and composition and colon cancer risk in women. Int J Cancer. 2006;118:1496–1500. doi: 10.1002/ijc.21508 16187280

26. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjonneland A, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006;98:920–931. doi: 10.1093/jnci/djj246 16818856

27. Oxentenko AS, Bardia A, Vierkant RA, Wang AH, Anderson KE, Campbell PT, et al. Body size and incident colorectal cancer: a prospective study of older women. Cancer Prev Res (Phila). 2010;3:1608–1620. doi: 10.1158/1940-6207.CAPR-10-0116

28. Hughes LAE, Simons CCJM, van den Brandt PA, Goldbohm RA, van Engeland M, Weijenberg MP. Body size and colorectal cancer risk after 16.3 years of follow-up: an analysis from the Netherlands Cohort Study. Am J Epidemiol. 2011;174:1127–1139. doi: 10.1093/aje/kwr247 21984660

29. Shin A, Joo J, Bak J, Yang H-R, Kim J, Park S, et al. Site-specific risk factors for colorectal cancer in a Korean population. PLoS ONE. 2011;6:e23196. doi: 10.1371/journal.pone.0023196 21853085

30. Wiren S, Haggstrom C, Ulmer H, Manjer J, Bjorge T, Nagel G, et al. Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control. 2014;25:151–159. doi: 10.1007/s10552-013-0317-7 24173535

31. Boursi B, Haynes K, Mamtani R, Yang Y-X. Height as an independent anthropomorphic risk factor for colorectal cancer. Eur J Gastroenterol Hepatol. 2014;26:1422–1427. doi: 10.1097/MEG.0000000000000209 25264984

32. Severson RK, Grove JS, Nomura AM, Stemmermann GN. Body mass and prostatic cancer: a prospective study. BMJ. 1988;297:713–715. 3147735

33. Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology. 1994;5:276–282. 8038241

34. Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, Tryggvadottir L. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev. 1997;6:863–873. 9367058

35. Nilsen TI, Vatten LJ. Anthropometry and prostate cancer risk: a prospective study of 22,248 Norwegian men. Cancer Causes Control. 1999;10:269–275. 10482485

36. Habel LA, Van Den Eeden SK, Friedman GD. Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort. Prostate. 2000;43:136–143. 10754529

37. Putnam SD, Cerhan JR, Parker AS, Bianchi GD, Wallace RB, Cantor KP, et al. Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men. Ann Epidemiol. 2000;10:361–369. 10964002

38. Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA. Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol. 2000;151:541–549. 10733035

39. Engeland A, Tretli S, Bjorge T. Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. Br J Cancer. 2003;89:1237–1242. doi: 10.1038/sj.bjc.6601206 14520453

40. Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, et al. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2006;15:1977–1983. 17035408

41. Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S. Association of body mass index and height with risk of prostate cancer among middle-aged Japanese men. Br J Cancer. 2006;94:740–742. doi: 10.1038/sj.bjc.6602983 16465189

42. Sequoia JSP, Wright ME, McCarron P, Pietinen P, Taylor PR, Virtamo J, et al. A prospective investigation of height and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15:2174–2178. doi: 10.1158/1055-9965.EPI-06-0467 17119043

43. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007;121:1571–1578. doi: 10.1002/ijc.22788 17450530

44. Littman AJ, White E, Kristal AR. Anthropometrics and prostate cancer risk. Am J Epidemiol. 2007;165:1271–1279. doi: 10.1093/aje/kwm013 17395597

45. Pischon T, Boeing H, Weikert S, Allen N, Key T, Johnsen NF, et al. Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2008;17:3252–3261. doi: 10.1158/1055-9965.EPI-08-0609 18990768

46. Zuccolo L, Harris R, Gunnell D, Oliver S, Lane JA, Davis M, et al. Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17:2325–2336. doi: 10.1158/1055-9965.EPI-08-0342 18768501

47. Ahn J, Moore SC, Albanes D, Huang W-Y, Leitzmann MF, Hayes RB. Height and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Br J Cancer. 2009;101:522–525. doi: 10.1038/sj.bjc.6605159 19568244

48. Hernandez BY, Park S-Y, Wilkens LR, Henderson BE, Kolonel LN. Relationship of body mass, height, and weight gain to prostate cancer risk in the multiethnic cohort. Cancer Epidemiol Biomarkers Prev. 2009;18:2413–2421. doi: 10.1158/1055-9965.EPI-09-0293 19723920

49. Wallstrom P, Bjartell A, Gullberg B, Olsson H, Wirfalt E. A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk. Br J Cancer. 2009;100:1799–1805. doi: 10.1038/sj.bjc.6605077 19436298

50. Stocks T, Hergens M-P, Englund A, Ye W, Stattin P. Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort. Int J Cancer. 2010;127:1660–1668. doi: 10.1002/ijc.25171 20087861

51. Bassett JK, Severi G, Baglietto L, MacInnis RJ, Hoang HN, Hopper JL, et al. Weight change and prostate cancer incidence and mortality. Int J Cancer. 2012;131:1711–1719. doi: 10.1002/ijc.27414 22213024

52. Shafique K, McLoone P, Qureshi K, Leung H, Hart C, Morrison DS. Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years’ follow up. BMC Cancer. 2012;12:25. doi: 10.1186/1471-2407-12-25 22260413

53. Zhang B, Shu X-O, Delahanty RJ, Zeng C, Michailidou K, Bolla MK, et al. Height and breast cancer risk: evidence from prospective studies and Mendelian randomization. J Natl Cancer Inst. 2015;107:djv219. doi: 10.1093/jnci/djv219 26296642

54. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301–1309. 1626547

55. Il’yasova D, Hertz-Picciotto I, Peters U, Berlin JA, Poole C. Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem. Cancer Causes Control. 2005;16:383–388. doi: 10.1007/s10552-004-5025-x 15953980

56. Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658–665. doi: 10.1002/gepi.21758 24114802

57. Hung RJ, Ulrich CM, Goode EL, Brhane Y, Muir K, Chan AT, et al. Cross cancer genomic investigation of inflammation pathway for five common cancers: lung, ovary, prostate, breast, and colorectal cancer. J Natl Cancer Inst. 2015;107:djv246. doi: 10.1093/jnci/djv246 26319099

58. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature. 2010;467:832–838. doi: 10.1038/nature09410 20881960

59. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512–525. doi: 10.1093/ije/dyv080 26050253

60. Humerfelt S, Eide GE, Kvåle G, Gulsvik A. Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) variability in asymptomatic never-smoking men. Clin Physiol. 1998;18:387–396. 9715766

61. Zacny JP, Stitzer ML, Brown FJ, Yingling JE, Griffiths RR. Human cigarette smoking: effects of puff and inhalation parameters on smoke exposure. J Pharmacol Exp Ther. 1987;240:554–564. 3806411

62. Tashkin DP, Clark VA, Coulson AH, Bourque LB, Simmons M, Reems C, et al. Comparison of lung function in young nonsmokers and smokers before and after initiation of the smoking habit. A prospective study. Am Rev Respir Dis. 1983;128:12–16. 6870055

63. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer. 2004;4:505–518. doi: 10.1038/nrc1387 15229476

64. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu J-L, et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest. 2002;110:771–781. doi: 10.1172/JCI15463 12235108

65. Rosenfeld RG. Insulin-like growth factors and the basis of growth. N Engl J Med. 2003;349:2184–2186. doi: 10.1056/NEJMp038156 14657423

66. Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363:1346–1353. doi: 10.1016/S0140-6736(04)16044-3 15110491

67. Fürstenberger G, Senn H-J. Insulin-like growth factors and cancer. Lancet Oncol. 2002;3:298–302. 12067807

68. Huang XP, Zhou WH, Zhang YF. Genetic variations in the IGF-IGFR-IGFBP axis confer susceptibility to lung and esophageal cancer. Genet Mol Res. 2014;13:2107–2119. doi: 10.4238/2014.January.24.17 24615087

69. Smith WJ, Underwood LE, Clemmons DR. Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab. 1995;80:443–449. doi: 10.1210/jcem.80.2.7531712 7531712

70. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst. 2000;92:1592–1600. 11018095

71. Boyle T, Fritschi L, Heyworth J, Bull F. Long-term sedentary work and the risk of subsite-specific colorectal cancer. Am J Epidemiol. 2011;173:1183–1191. doi: 10.1093/aje/kwq513 21421743

72. Zhang H-J, Wang H-Y, Zhang H-T, Su J-M, Zhu J, Wang H-B, et al. Transforming growth factor-β1 promotes lung adenocarcinoma invasion and metastasis by epithelial-to-mesenchymal transition. Mol Cell Biochem. 2011;355:309–314. doi: 10.1007/s11010-011-0869-3 21695462

73. Shaw A, Gipp J, Bushman W. The Sonic Hedgehog pathway stimulates prostate tumor growth by paracrine signaling and recapitulates embryonic gene expression in tumor myofibroblasts. Oncogene. 2009;28:4480–4490. doi: 10.1038/onc.2009.294 19784071

74. Yue D, Li H, Che J, Zhang Y, Tseng H-HK, Jin JQ, et al. Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas. J Exp Clin Cancer Res. 2014;33:34. doi: 10.1186/1756-9966-33-34 24758269

75. Thrift AP, Gong J, Peters U, Chang-Claude J, Rudolph A, Slattery ML, et al. Mendelian randomization study of height and risk of colorectal cancer. Int J Epidemiol. 2015;44:662–672. doi: 10.1093/ije/dyv082 25997436

76. Davies NM, Gaunt TR, Lewis SJ, Holly J, Donovan JL, Hamdy FC, et al. The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. Cancer Causes Control. 2015;26:1603–1616. doi: 10.1007/s10552-015-0654-9 26387087

77. Burgess S. Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int J Epidemiol. 2014;43:922–929. doi: 10.1093/ije/dyu005 24608958